Ibrahim B. Dagher
CIK: 0002019599
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
BCLI
BRAINSTORM CELL THERAPEUTICS INC.
Officer
Discretionary Trading P&L
Holdings
About Dagher Ibrahim B.
Dagher Ibrahim B. (SEC CIK 0002019599) files insider reports with the SEC as Chief Medical Officer of BRAINSTORM CELL THERAPEUTICS INC. (BCLI).
Signal8 holds 3 ownership filings by Dagher Ibrahim B. (1 Form 3, 2 Form 4), filed between Jan 7, 2025 and May 20, 2026. Those filings report 2 transactions, from Jan 1, 2025 to Feb 26, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Dagher Ibrahim B.'s filings is in NEW YORK, NY.
Recent filings by Dagher Ibrahim B.
Other insiders filing for BRAINSTORM CELL THERAPEUTICS INC. (BCLI)
- FRENKEL JACOB A, Director
- Pitts Peter Joe, Executive Chairman
- Lebovits Chaim, President & CEO
- Yablonka Uri, EVP & Chief Business Officer
- Patlis Alla
- ARBEL IRIT, Director